Spironolactone
Alternative Names: Aldactone
Spironolactone is a potassium-sparing diuretic and aldosterone antagonist used as an add-on therapy for heart failure with reduced ejection fraction (HFrEF), particularly in patients with persistent symptoms (NYHA class II–IV) despite standard treatment. It works by blocking aldosterone, which helps reduce sodium and water retention, prevent cardiac remodeling, and improve survival. Spironolactone has been shown to lower mortality and hospital.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the review, Spironolactone appears to be an effective treatment for Congestive Heart Failure, particularly for patients with reduced ejection fraction. The medication has been shown to reduce mortality and hospitalization rates, though it requires careful monitoring for potential side effects like hyperkalemia and renal function changes.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
5.0
AI Summary of User Experiences
Not medical advice.
Based on the review, Spironolactone appears to be an effective treatment for Congestive Heart Failure, particularly for patients with reduced ejection fraction. The medication has been shown to reduce mortality and hospitalization rates, though it requires careful monitoring for potential side effects like hyperkalemia and renal function changes.
Reviews
Filter by reviewer type Pro